A characteristic of polyglutamine diseases is the increased propensity of disease proteins to aggregate, which is thought to be a major contributing factor to the underlying neurodegeneration. Healthy cells contain mechanisms for handling protein damage, the protein quality control, which must be impaired or inefficient to permit proteotoxicity under pathological conditions
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
Neurodegenerative disorders are a group of hereditary and sporadic conditions that are characterized...
Proteolytic cleavage has been implicated in the pathogenesis of diverse neurodegenerative diseases i...
K. Seidel, M. Meister, G. J. Dugbartey, M. P. Zijlstra, J. Vinet, E. R. P. Brunt, F. W. van Leeuwen,...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
Neurodegenerative disorders are often characterized by the aggregation and accumulation of misfolded...
Neurodegenerative diseases, including motor neuron and polyglutamine (polyQ) diseases, are a broad c...
Properly folded, functional proteins are essential for cell health. Cells sustain protein homeostasi...
The pathophysiology of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and ...
Aggregation of Abeta plays a key role in the pathogenesis of Alzheimer's disease. Although the highl...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...
Insoluble protein aggregates are consistently found in neurodegenerative disorders caused by expande...
AbstractNine inherited neurodegenerative disorders result from polyglutamine expansions. Two recentl...
The incidence of neurodegenerative diseases such as Alzheimer\u27s Disease, Parkinson\u27s Disease, ...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
Neurodegenerative disorders are a group of hereditary and sporadic conditions that are characterized...
Proteolytic cleavage has been implicated in the pathogenesis of diverse neurodegenerative diseases i...
K. Seidel, M. Meister, G. J. Dugbartey, M. P. Zijlstra, J. Vinet, E. R. P. Brunt, F. W. van Leeuwen,...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
Neurodegenerative disorders are often characterized by the aggregation and accumulation of misfolded...
Neurodegenerative diseases, including motor neuron and polyglutamine (polyQ) diseases, are a broad c...
Properly folded, functional proteins are essential for cell health. Cells sustain protein homeostasi...
The pathophysiology of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and ...
Aggregation of Abeta plays a key role in the pathogenesis of Alzheimer's disease. Although the highl...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...
Insoluble protein aggregates are consistently found in neurodegenerative disorders caused by expande...
AbstractNine inherited neurodegenerative disorders result from polyglutamine expansions. Two recentl...
The incidence of neurodegenerative diseases such as Alzheimer\u27s Disease, Parkinson\u27s Disease, ...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
Neurodegenerative disorders are a group of hereditary and sporadic conditions that are characterized...
Proteolytic cleavage has been implicated in the pathogenesis of diverse neurodegenerative diseases i...